TREOSULFAN for Diffuse large b-cell lymphoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 17 adverse event reports in the FDA FAERS database where TREOSULFAN was used for Diffuse large b-cell lymphoma.
Most Reported Side Effects for TREOSULFAN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 418 | 24.4% | 81 | 53 |
| Cytomegalovirus infection | 211 | 12.3% | 18 | 10 |
| Mucosal inflammation | 199 | 11.6% | 34 | 36 |
| Cytomegalovirus infection reactivation | 190 | 11.1% | 18 | 20 |
| Adenovirus infection | 168 | 9.8% | 41 | 19 |
| Product use in unapproved indication | 161 | 9.4% | 23 | 18 |
| Acute graft versus host disease in skin | 145 | 8.5% | 25 | 18 |
| Drug ineffective | 117 | 6.8% | 26 | 27 |
| Graft versus host disease in skin | 109 | 6.4% | 17 | 9 |
| Human herpesvirus 6 infection | 104 | 6.1% | 13 | 7 |
| Neutropenia | 94 | 5.5% | 10 | 2 |
| Multiple organ dysfunction syndrome | 91 | 5.3% | 81 | 26 |
| Acute graft versus host disease | 90 | 5.3% | 7 | 17 |
| Pyrexia | 84 | 4.9% | 18 | 39 |
| Graft versus host disease in gastrointestinal tract | 80 | 4.7% | 19 | 16 |
Other Indications for TREOSULFAN
Bone marrow conditioning regimen (695)
Allogenic stem cell transplantation (397)
Prophylaxis against transplant rejection (136)
Stem cell transplant (108)
Immunosuppressant drug therapy (76)
Prophylaxis against graft versus host disease (58)
Product used for unknown indication (56)
Immunosuppression (46)
Acute myeloid leukaemia (38)
Sickle cell disease (36)
Other Drugs Used for Diffuse large b-cell lymphoma
RITUXIMAB (22,275)
CYCLOPHOSPHAMIDE (16,598)
DOXORUBICIN (15,213)
VINCRISTINE (14,922)
PREDNISONE (11,266)
LENALIDOMIDE (7,858)
ETOPOSIDE (4,698)
PREDNISOLONE (4,086)
CYTARABINE (3,857)
DEXAMETHASONE (3,696)